Procognia is a Contract Research Organization (CRO), providing analytical services to biopharmaceutical and biosimilar companies. We assist our customers in directing their products towards optimal glycosylation, for improved efficacy and safety. For biosimilar manufacturers, our services can direct clone and cell line selection and manufacturing conditions towards a product with glycosylation profiles similar to the original product, as required by the regulatory authorities. Our Services include: • N-link glycan analysis by HPLC • O-link glycan analysis by HPLC • Profiling and quantitative analysis of sialic acid • Quantitative monosaccharide analysis • High throughput glycosylation analysis using GlycoScope™ • Consulting Procognia's extensive experience, successful track record as a service provider for global biopharmaceutical companies, and its team of experts, provides integrated ICH guidelines compliant solutions, for your company’s glycosylation analysis needs.